What You Should Know:
- Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M.
- The initial Series D funding round was announced in April and was led by global growth equity firm General Atlantic with participation by CVS Health (NYSE:CVS), Trevor
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Evidence Partners Raises $20M for Automated, Evidence-Based Research
What You Should Know:
- Evidence Partners has announced a growth financing round, their first ever, for $20M, led by Thomvest Ventures.
- With their new AI product DistillerSR, Evidence Partners are changing the way Literature Reviews are conducted, making them efficient, accurate, and less labour-intensive.
AI-Driven Literature Review Software
DistillerSR is a web-based platform that allows researchers to collaborate concurrently on the same projects from anywhere, without
Read More
Sibel Health Raises $33M for Advanced Wearable Sensors for RPM
What You Should Know:
- Sibel Health has recently closed a $33M Series B financing round, bringing Sibel's total funding to date to more than $50M.
- In addition, Sibel has announced two new executive appointments. Jon Otterstatter, the former CEO and co-founder of Preventice (acquired by Boston Scientific in 2021), will join as chairman of the board. Matthew Banet, Ph.D., a world expert in advanced body-worn sensors and previously the CTO and co-founder of toSense and Sotera, joins as
Read More
Diagnostic Robotics Raises $45M for Medical-Grade AI Triage & Clinical Predictions Platform
What You Should Know:
- Diagnostic Robotics has announced the closing of a $45M Series B funding round led by StageOne investors, with participation from Mayo Clinic, thus becoming a Mayo Clinic Platform portfolio company. Technion – Israel Institute of Technology, as well as other existing investors such as strategic angel investor Bradley Bloom, co-founder of Berkshire Partners, participated in this funding round as well.
- The new funding will be used to accelerate product development,
Read More
Homeward Raises $50M, Inks Value-Based Contract with Priority Health
What You Should Know:
- Homeward raises $50M Series B funding round co-led by ARCH Venture Partners and Human Capital.
- The funding round also includes participation from General Catalyst, which led Homeward’s Series A funding, and Lee Shapiro and Glen Tullman, Co-Founders of 7wireVentures, one of the country’s most successful early-stage healthcare venture funds.
Value-Based and Comprehensive Care
Americans living in rural communities are experiencing increasing health disparities
Read More
Annexus Health Raises $33M to Optimize Patient Access and Affordability
What You Should Know:
- Annexus Health, Inc. has announced its Series B financing of $33 million, which was led by leading digital health growth equity firm Transformation Capital.
- The funding is set to advance Annexus Health's mission to improve access to care and combat patient financial toxicity amid ever-rising healthcare costs
Re-Imagining the Healthcare Ecosystem by Increasing Access To Care
Annexus Health strives for a better healthcare experience for patients, more
Read More
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
Elevation Oncology Secures $50M Loan Facility with K2 HealthVentures
What You Should Know:
Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50M senior secured loan facility from funds managed by K2 HealthVentures.
Elevation plans to use the funding from the facility will primarily support the exclusive license of EO-3021 (SYSA1801) outside of Greater China from CSPC Pharmaceutical Group and the
Read More
Syapse Raises $35M to Expand Learning Health Network
What You Should Know:
- Syapse raises $35M led by an affiliate of Innovatus Capital Partners, LLC (Innovatus)to tackle the challenge of understanding, preventing, and treating complex cancers.
- The investment will allow Syapse to expand its artificial intelligence and machine learning capabilities, making it more efficient to uncover meaningful insights from real-world oncology data.
Syapse, a San Francisco, CA-based real-world evidence company accelerating the
Read More
VC General Catalyst Closes $675M Health Assurance Fund II
What You Should Know:
- Early-stage venture capital firm General Catalyst closes $670 million Health Assurance Fund II.
- The new fund comes on the heels of the Health Assurance Fund I closed in April of 2021 at $600M. To date, General Catalyst has invested $1.7B in companies aligned with the health assurance thesis.
Health Assurance Fund II Investment Thesis
This new fund will allow us to continue to accelerate General Catalyst’s work on building a value-oriented system and focus
Read More
